$0.15
+0.00 (+3.26%)
Open$0.14
Previous Close$0.14
Day High$0.16
Day Low$0.14
52W High$0.77
52W Low$0.03
Volume—
Avg Volume1.27M
Market Cap58.00M
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+13,806.8% upside
Current
$0.15
$0.15
Target
$20.29
$20.29
$11.90
$20.29 avg
$29.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.13M | 79.25M | 23.70M |
| Net Income | -174,398,855 | -221,599,561 | -3,056,252 |
| Profit Margin | -310.8% | -295.3% | -12.9% |
| EBITDA | -166,408,390 | -223,193,520 | -4,785,189 |
| Free Cash Flow | — | — | -2,136,953 |
| Rev Growth | -29.2% | -29.2% | +16.7% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |